Publications
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Mathematics and Physics, Second Faculty of Medicine
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | First Faculty of Medicine
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Serum infliximab trough levels and induction of antibodies to infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Concentrations of sRAGE in Serum and Follicular Fluid in Assisted Reproductive Cycles - a Preliminary Study2010 | First Faculty of Medicine
- Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes2010 | First Faculty of Medicine
- PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)Publication without faculty affiliation
- Relationship Between Serum Trough Infliximab Levels and Serum Albumin in Patients With Inflammatory Bowel DiseasesPublication without faculty affiliation
- Determination of serum infliximab levels and levels of antibodies against infliximab - when, why and how?Publication without faculty affiliation
- Serum infliximab levels, antibodies to infliximab and albumin concentrations during infliximab treatment in patients with inflammatory bowel diseasesPublication without faculty affiliation
Loading network view...
